Patents Assigned to Sequenom, Inc.
  • Patent number: 6207370
    Abstract: The invention provides a means of detecting and identifying mutations in a genetic region, and a means of quantifying the number of repeat units in, for example, a trinucleotide repeat, by transcription/translation of the genetic region into a target polypeptide. The method requires neither radioisotopic nor fluorescent labeling of the target polypeptide. In particular, the invention is based on mass spectrometric determination of the mass of the encoded target polypeptide and comparison of the mass of the polypeptide with its own expected mass or with the mass of a polypeptide of known identity. Depending on the target polypeptide to be identified, the processes can be used, for example, to diagnose a genetic disease or chromosomal abnormality; a predisposition to a disease or condition, infection by a pathogenic organism, or for determining identity or heredity.
    Type: Grant
    Filed: September 2, 1997
    Date of Patent: March 27, 2001
    Assignee: Sequenom, Inc.
    Inventors: Daniel P. Little, Scott Higgins, Hubert Köster
  • Patent number: 6197498
    Abstract: Fast and highly accurate mass spectrometry-based processes for detecting particular nucleic acid molecules and sequences in the molecules are provided. Depending upon the sequence to be detected, the processes, for example, can be used to diagnose a genetic disease or a chromosomal abnormality, a predisposition to a disease or condition, or infection by a pathogen, or for determining identity or heredity.
    Type: Grant
    Filed: April 6, 1999
    Date of Patent: March 6, 2001
    Assignee: Sequenom, Inc
    Inventor: Hubert Köster
  • Patent number: 6194144
    Abstract: The invention describes a new method to sequence DNA. The improvements over the existing DNA sequencing technologies are high speed, high throughput, no electrophoresis and gel reading artifacts due to the complete absence of an electrophoretic step, and no costly reagents involving various substitutions with stable isotopes. The invention utilizes the Sanger sequencing strategy and assembles the sequence information by analysis of the nested fragments obtained by base-specific chain termination via their different molecular masses using mass spectrometry, as for example, MALDI or ES mass spectrometry. A further increase in throughput can be obtained by introducing mass-modifications in the oligonucleotide primer, chain-terminating nucleoside triphosphates and/or in the chain-elongating nucleoside triphosphates, as well as using integrated tag sequences which allow multiplexing by hybridization of tag specific probes with mass differentiated molecular weights.
    Type: Grant
    Filed: March 18, 1996
    Date of Patent: February 27, 2001
    Assignee: Sequenom, Inc.
    Inventor: Hubert Köster
  • Patent number: 6146854
    Abstract: Processes, kits and preferred devices for rapidly isolating large numbers of plasmid DNAs from plasmid containing cells and for performing high throughput DNA sequencing are described.
    Type: Grant
    Filed: August 31, 1995
    Date of Patent: November 14, 2000
    Assignee: Sequenom, Inc.
    Inventors: Hubert Koster, Andreas Ruppert
  • Patent number: 6140053
    Abstract: The invention provides fast and highly accurate mass spectrometer based processes for directly sequencing a target nucleic acid (or fragments generated from the target nucleic acid), which by means of protection, specificity of enzymatic activity, or immobilization, are unilaterally degraded in a stepwise manner via exonuclease digestion and the nucleotides, derivatives or truncated sequences detected by mass spectrometry.
    Type: Grant
    Filed: September 25, 1998
    Date of Patent: October 31, 2000
    Assignee: Sequenom, Inc.
    Inventor: Hubert Koster
  • Patent number: 6133436
    Abstract: Novel compositions comprised of at least one bead conjugated to a solid support and further conjugated to at least one nucleic acid and preferred methods for making the novel compositions are described. As compared to "flat" surfaces, beads linked to a solid support provide an increased surface area for immobilization of nucleic acids. Furthermore, by selecting a bead with the desired functionality, a practitioner can select a functionalization chemistry for immobilizing nucleic acids, which is different from the chemistry of the solid support.
    Type: Grant
    Filed: September 19, 1997
    Date of Patent: October 17, 2000
    Assignee: Sequenom, Inc.
    Inventors: Hubert Koster, David M. Lough
  • Patent number: 6111251
    Abstract: Matrix assisted laser desorption/ionization is performed in a manner to thermalize large analyte ions in a plume of desorbed material for spectroscopic analysis. The thermalized ions have a low or zero mean velocity and are presented at a well-defined instant in time, reducing artifacts and sharpening the spectral peaks. In one embodiment the light is delivered to a matrix or sample holder having a cover, baffle or compartment. The baffle or compartment impedes or contains a plume of desorbed material and the analyte undergoes collisions to lower its mean velocity and directionality. Thus "thermalized" the analyte ions are passed to a mass analysis instrument. In a preferred embodiment an optical fiber butts up against a thin transparent plate on which the specimen resides, with the matrix side in a vacuum acceleration chamber. A mechanical stage moves the specimen in both the x- and y-directions to select a point on the specimen which is to receive the radiation.
    Type: Grant
    Filed: September 19, 1997
    Date of Patent: August 29, 2000
    Assignee: Sequenom, Inc.
    Inventor: Franz Hillenkamp
  • Patent number: 6074823
    Abstract: The invention provides fast and highly accurate mass spectrometer based processes for directly sequencing a target nucleic acid (or fragments generated from the target nucleic acid), which by means of protection, specificity of enzymatic activity, or immobilization, are unilaterally degraded in a stepwise manner via exonuclease digestion and the nucleotides, derivatives or truncated sequences detected by mass spectrometry.
    Type: Grant
    Filed: November 6, 1996
    Date of Patent: June 13, 2000
    Assignee: Sequenom, Inc.
    Inventor: Hubert Koster
  • Patent number: 6043031
    Abstract: The invention provides fast and highly accurate mass spectrometer based processes for detecting a particular nucleic acid sequence in a biological sample. Depending on the sequence to be detected, the processes can be used, for example, to diagnose a genetic disease or chromosomal abnormality; a predisposition to a disease or condition, infection by a pathogenic organism, or for determining identity or heredity.
    Type: Grant
    Filed: March 18, 1996
    Date of Patent: March 28, 2000
    Assignee: Sequenom, Inc.
    Inventors: Hubert Koster, G. Scott Higgens, Daniel P. Little
  • Patent number: 6024925
    Abstract: The invention provides, in one aspect, serial and parallel dispensing tools that can deliver defined and controlled volumes of fluid to generate multi-element arrays of sample material on a substrate surface. The substrates surfaces can be flat or geometrically altered to include wells of receiving material. In one embodiment, the invention provides a tool that allows the parallel development of a sample array. To this end, the tool can be understood as an assembly of vesicle elements, or pins, wherein each of the pins can include a narrow interior chamber suitable for holding manual liter volumes of fluid. Each of the pins can fit inside a housing that forms an interior chamber. The interior chamber can be connected to a pressure source that will control the pressure within the interior chamber to regulate the flow of fluid within the interior chamber of the pins.
    Type: Grant
    Filed: January 23, 1997
    Date of Patent: February 15, 2000
    Assignee: Sequenom, Inc.
    Inventors: Daniel P. Little, Hubert Koster
  • Patent number: 6022688
    Abstract: A method for dissociating a complex of a biotin compound and a biotin-binding compound, by contacting the complex with an amine, is disclosed.
    Type: Grant
    Filed: May 13, 1996
    Date of Patent: February 8, 2000
    Assignee: Sequenom, Inc.
    Inventors: Christian Jurinke, Dirk Van den Boom, Hubert Koster
  • Patent number: 5928906
    Abstract: Processes and kits for simultaneously amplifying and sequencing nucleic acid molecules, and perfonning high throughput DNA sequencing are described.
    Type: Grant
    Filed: May 9, 1996
    Date of Patent: July 27, 1999
    Assignee: Sequenom, Inc.
    Inventors: Hubert Koster, Dirk Van Den Boom, Andreas Ruppert
  • Patent number: 5900481
    Abstract: Novel compositions comprised of at least one bead conjugated to a solid support and further conjugated to at least one nucleic acid and preferred methods for making the novel compositions are described. As compared to "flat" surfaces, beads linked to a solid support provide an increased surface area for immobilization of nucleic acids. Furthermore, by selecting a bead with the desired functionality, a practitioner can select a functionalization chemistry for immobilizing nucleic acids, which is different from the chemistry of the solid support.
    Type: Grant
    Filed: November 6, 1996
    Date of Patent: May 4, 1999
    Assignee: Sequenom, Inc.
    Inventors: David M. Lough, Hubert Koster
  • Patent number: 5872003
    Abstract: Methods for determining the sequence of nucleic acids by cleaving the nucleic acid unilaterally from a first end with an exonuclease activity to sequentially release individual nucleotides, identifying each of the sequentially release nucleotides by mass spectrometry, and determining the sequence of the nucleic acid from the identified nucleotides are disclosed. The method is amenable to multiplexing for simulataneously determining more than one nuleic acid sequence.
    Type: Grant
    Filed: May 30, 1995
    Date of Patent: February 16, 1999
    Assignee: Sequenom, Inc.
    Inventor: Hubert Koster
  • Patent number: 5777324
    Abstract: Matrix assisted laser desorption/ionization is performed in a manner to thermalize large analyte ions in a plume of desorbed material for spectroscopic analysis. The thermalized ions have a low or zero mean velocity and are presented at a well-defined instant in time, reducing artifacts and sharpening the spectral peaks. In one embodiment the light is delivered to a matrix or sample holder having a cover, baffle or compartment. The baffle or compartment impedes or contains a plume of desorbed material and the analyte undergoes collisions to lower its mean velocity and directionality. Thus "thermalized" the analyte ions are passed to a mass analysis instrument. In a preferred embodiment an optical fiber butts up against a thin transparent plate on which the specimen resides, with the matrix side in a vacuum acceleration chamber. A mechanical stage moves the specimen in both the x- and y-directions to select a point on the specimen which is to receive the radiation.
    Type: Grant
    Filed: September 19, 1996
    Date of Patent: July 7, 1998
    Assignee: Sequenom, Inc.
    Inventor: Franz Hillenkamp
  • Patent number: 5691141
    Abstract: The invention describes a new method to sequence DNA. The improvements over the existing DNA sequencing technologies are high speed, high throughput, no electrophoresis and gel reading artifacts due to the complete absence of an electrophoretic step, and no costly reagents involving various substitutions with stable isotopes. The invention utilizes the Sanger sequencing strategy and assembles the sequence information by analysis of the nested fragments obtained by base-specific chain termination via their different molecular masses using mass spectrometry, as for example, MALDI or ES mass spectrometry. A further increase in throughput can be obtained by introducing mass-modifications in the oligonucleotide primer, chain-terminating nucleoside triphosphates and/or in the chain-elongating nucleoside triphosphates, as well as using integrated tag sequences which allow multiplexing by hybridization of tag specific probes with mass differentiated molecular weights.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: November 25, 1997
    Assignee: Sequenom, Inc.
    Inventor: Hubert Koster
  • Patent number: 5622824
    Abstract: Methods for determining the sequence of nucleic acids by cleaving the nueleic acid unilaterally from a first end with an exonuclease activity to sequentially release individual nucleotides, identifying each of the sequentially release nucleotides by mass spectrometry, and determining the sequence of the nueleic acid from the identified nucleotides are disclosed. The method is amenable to multiplexing for simultaneously determining more than one nucleic acid sequence.
    Type: Grant
    Filed: February 10, 1995
    Date of Patent: April 22, 1997
    Assignee: Sequenom, Inc.
    Inventor: Hubert K oster
  • Patent number: 5605798
    Abstract: The invention provides fast and highly accurate mass spectrometer based processes for detecting a particular nucleic acid sequence in a biological sample. Depending on the sequence to be detected, the processes can be used, for example, to diagnose (e.g. prenatally or postnatally) a genetic disease or chromosomal abnormality; a predisposition to a disease or condition (e.g. obesity, artherosclerosis, cancer), or infection by a pathogenic organism (e.g. virus, bacteria, parasite or fungus).
    Type: Grant
    Filed: March 17, 1995
    Date of Patent: February 25, 1997
    Assignee: Sequenom, Inc.
    Inventor: Hubert Koster
  • Patent number: 5547835
    Abstract: The invention describes a new method to sequence DNA. The improvements over the existing DNA sequencing technologies are high speed, high throughput, no electrophoresis and gel reading artifacts due to the complete absence of an electrophoretic step, and no costly reagents involving various substitutions with stable isotopes. The invention utilizes the Sanger sequencing strategy and assembles the sequence information by analysis of the nested fragments obtained by base-specific chain termination via their different molecular masses using mass spectrometry, as for example, MALDI or ES mass spectrometry. A further increase in throughput can be obtained by introducing mass-modifications in the oligonucleotide primer, chain-terminating nucleoside triphosphates and/or in the chain-elongating nucleoside triphosphates, as well as using integrated tag sequences which allow multiplexing by hybridization of tag specific probes with mass differentiated molecular weights.
    Type: Grant
    Filed: January 6, 1994
    Date of Patent: August 20, 1996
    Assignee: Sequenom, Inc.
    Inventor: Hubert Koster